Merck
HomeServicesContract ManufacturingADC & Bioconjugation

ADC & Bioconjugation

With more than 35 years of experience, we are a leading expert in the conjugation of highly active molecules to monoclonal antibodies for the development and manufacture of antibody-drug conjugates (ADCs).

Request Information

Targeted Delivery Through Conjugation

Antibody-drug conjugation technology uses monoclonal antibodies or other biologics to deliver highly active or potent pharmaceutical ingredients (HPAPIs) to targeted cells. In conjugated form, the HPAPIs exhibits more selective therapeutic activity, sparing non-target cells from many of the toxic effects and improving the safety profile. Customers are quickly adapting these complex technologies and employing them to develop new oncology and non-oncology products that are more targeted and safer.

Drug Discovery

ChetoSensar™: consider it disSolved. A technology that solves many challenges with antibody-drug conjugates

Do you need to rescue your ADC program? Poor solubility of ADCs represents a significant challenge leading to painstaking efforts to rescue these programs. Our ChetoSensar™ technology can help to improve the solubility of ADCs and provides access to highly hydrophobic novel payloads that might not be considered. Find out how you can try this technology to improve solubility, reduce aggregation, improve therapeutic index & conjugation efficiency, and achieve higher drug-to-antibody ratio for your ADC program.

Candidate Selection

Our ADC Express™ discovery conjugation services help accelerate production of development-grade ADC constructs with essential analytical characterization of key quality attributes.

The combination of our extensive bioconjugation expertise and proven platform technology will efficiently turn your antibody and/or linker and payload into an ADC, enable scaling and shorten your path to the clinic.

ADC Express™ Features
  • Mini-prep scale: 10–20 mg ADC construct ± column purification
  • Medium-prep scale: up to 100 mg ADC ± column purification
  • Certificate of testing with key quality attributes
  • ADC concentration
  • Payload density/DAR (drug antibody ratio)
  • Monomer/aggregate content
  • Free residual payload

Technology Expertise

We have the right experience and expertise to support your ADC or bioconjugate project:

  • Development experience with more than 65 different ADC constructs and more than 600 batches
  • GMP experience with more than 25 different ADC constructs and more than 110 batches
  • Random cysteine or lysine conjugation technology
  • site-specific conjugation via engineered mAbs or enzyme catalyzed
  • Non-natural amino acids (NAA)
  • Various payloads - auristatins, PBD, Tubulysins, Maytansinoids and custom toxins
  • Extensive analytical capabilities for characterization, including mass spec
  • Release testing and stability for both bulk drug substance (BDS) and drug product (DP)
  • Personnel and suites dedicated to ADC development, manufacturing, and testing

Dedicated Manufacturing Facilities

Our clinical ADC manufacturing facility was purpose-built for handling HPAPIs, antibodies, linkers and for performing complex conjugation processes in a cGMP suite featuring isolators and specialized handling equipment.

  • SafeBridge®-Certifiation
  • 800 sq-ft footprint including airlocks
  • ISO 8 classified clean room environment
  • Unidirectional personnel flow with entry, de-gown, and exit airlocks
  • Personnel airlocks separate from equipment/material airlocks

Our 10,000 square foot commercial-scale manufacturing facility supports clinical Phase I/II/III and commercial ADCs and features:

  • SafeBridge®- Certification
  • Unidirectional flow (personnel and materials/equipment)
  • Rated for flammable use
  • WFI system
  • Drug weigh-up room (Grade C)
  • Isolator for drug-linker weigh up
  • Single pass air
  • Sequential airlocks designed for cGMP/containment

GMP mAb Production

Our BioReliance® Biodevelopment Center at Martillac, France offers state-of-the-art GMP mAb production. Click here to learn more.

Project Management & Supporting Services

Our comprehensive ADC solutions include analytical and process support throughout all stages of drug development and manufacture.

The analytical services include development of specifications, risk assessment, implementation of process controls and validated cleaning procedures. We also offer

  • Phase-specific analytical development
  • QC testing of in-process materials
  • Release testing of BDS and DP
  • Stability Programs for our BDS and DP
  • Analytical instrumentation, including: MS, HPLC, iCE/IEF,CGE, ELISA, UV, NMR, IR

From evaluation to execution, our highly skilled and dedicated project managers are responsible for coordinating multi-disciplinary teams, international site activities and timelines:

  • Dedicated and transparent approach to ensure a positive customer experience
  • Globally harmonized best practices
  • Responsive and solution driven
  • Flexible and collaborative

Simplifying the Pathway to Patients

Our ADC Contract Manufacturing footprint offers integrated solutions for your antibody-drug conjugate. Click here for more information on our comprehensive ADC solutions.

Offering you a world of capabilities

The global footprint of our contract manufacturing services assures you of wide-ranging regulatory and supply expertise, easily accessed through a single trusted partner. Learn more about our locations:

Related Product Resources

Case Study: Complete Single-Use ADC Technology from Development Through Scale-up
Flyer: ChetoSensar: Consider it DisSolved
Flyer: Discover Comprehensive ADC Solutions
Flyer: ADC Express™ Pre-clinical Conjugation Services for the Best Candidate Selection
Flyer: DM1 - Mertansine GMP Quality Payload for Your Drug Conjugate Programs
Flyer: Synthesise Dolastatin Payloads Faster and with Less Risk
Webinar: The Evolution of ADC Manufacturing Expertise During the Last 10 Years
Webinar: Complete Single-use ADC Technology from Development Through Scale-up
Webinar: Commercializing Antibody-Drug Conjugates: a CMO’s Journey
White Paper: Commercializing Antibody-Drug Conjugates: a CMO’s Journey
Video: ADC Express Discovery Conjugation Services for the Best Candidate Selection

Related Services

High Potent APIs
Our HPAPI contract manufacturing services can support all stages of your project. Partner with an industry leader offering a global footprint and decades of experience for your drug development and manufacturing, leveraging our dedicated team and broad product portfolio with single-point project management.
Activated PEG Contract Manufacturing Services
Our PEGs contract manufacturing services can support all stages of your project. Partner with an industry leader offering a global footprint and decades of experience for your drug development and manufacturing, leveraging our dedicated team and broad product portfolio with single-point project management.
ADC Characterization
As your characterization partner we can provide expert guidance on the biological components of your antibody drug conjugate (ADC) – conducting safer, more reliable, and faster testing that helps to expedite product quality decisions at critical junctures.
mAb Product Characterization
When moving your monoclonal antibody (mAb) from concept to clinic, our product characterization services and assay packages help ensure your biotherapy’s safety, purity, and potency while expediting quality decisions at every stage.
mAb Manufacturing
BioReliance® End-to-End Solutions is your biologic CDMO partner for clinical and commercial drug substance manufacturing on any scale, providing flexible custom solutions based on scientific knowledge, operational excellence, quality, and regulatory compliance.
Emprove® Program
Confidently speed your way through the regulatory maze and fast track your new drug to market with the Emprove® Program. High-quality products, comprehensive documentation, and superior customer support facilitate your efforts in qualification, risk assessment, and process optimization.

Related Product Categories

Buffers & pH Adjusters
Our broad portfolio of buffer materials manufactured according to GMP guidelines includes excipients specifically for drug formulation and manufacturing, including high-risk applications. Whether your product is a small or large molecule drug, we offer high-quality buffers and pH adjusters with regulatory support.
Biomolecule Formulation
Specifically developed for high-risk biopharmaceutical applications, our high-quality process chemicals and excipients help you to minimize the regulatory and quality-associated risks of biomolecule formulation.
Protein Stabilizers
Our high-quality protein stabilizers provide the control you need for successful biopharmaceutical formulations and efficient processing, backed by comprehensive Emprove® documentation to help minimize regulatory and quality-associated risks.

Related Applications

Antibody-Drug Conjugate (ADC) Manufacturing
Antibody-drug conjugation (ADC) technology uses monoclonal antibodies (mAbs) to deliver potent, highly active pharmaceutical ingredients (HPAPIs) to targeted cells. Learn about processes and areas of expertise required to advance your ADC to market.
ADC & Bioconjugation
Bioconjugation involves ligating molecules together in which at least one of the reactants is a biomolecule, often an antibody, protein, or oligonucleotide, for detection, assay, or targeting and tracking of the biomolecule.
Monoclonal Antibody Manufacturing
Monoclonal antibody manufacturing is a highly templated approach used to produce mAb-based immunotherapies. Robust, scalable process solutions are required at every step to ensure high therapeutic concentration and process safety, while meeting speed-to-market and cost containment concerns.
Biotech Resource Hub
Your new molecule or therapy begins its journey here. Find solutions and resources to navigate your path to successful drug discovery, development, and commercialization.

Related Videos

Slide 1 of 2